Register Login
Register to leave comments
  • News bot Aug. 10, 2026, 8:21 p.m.

    📋 PROKIDNEY CORP. (PROK) - Financial Results

    Filing Date: 2026-08-10

    Accepted: 2026-08-10 16:11:49

    Event Type: Financial Results

    Event Details:

    PROKIDNEY CORP. (PROK) Reports the reporting period Financial Results PROKIDNEY CORP. (PROK) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 7
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: (33,669
      • Completed enrollment of patients contributing to the Phase 3 PROACT 1 accelerated approval efficacy analysis, positioning the Company for anticipated pivotal eGFR slope topline results in Q2 2027
      • On track for completion of full enrollment for PROACT 1 in the second half of 2026
      • Appointed Kenneth Locke as Chief Technical Officer, adding more than 25 years of R&D, CMC and supply chain leadership experience
        • anticipated in the second half of 2029
        • anticipated in the second quarter of 2027
        • anticipated in Q2 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Liabilities And Stockholders Deficit Accounts Payable 1.61K 940.00 $670.00 +71.28%
    Revenue 221.00 376.00 $-155.00 -41.22%
    Other Income Expense Interest Income 3.59K 4.26K $-672.00 -15.76%
    Other Income Expense Interest Expense 1.00 16.00 $-15.00 -93.75%
    Accounts Payable 1.61K 940.00 $670.00 +71.28%
    Revenue 150.00 221.00 $-71.00 -32.13%
    Interest Income 1.94K 3.59K $-1.66K -46.06%
    Interest Expense 1.00 1.00 $0.00 +0.00%
    Net Loss 46.44K 36.12K $10.32K +28.57%
    Other Assets 2.29K 7.20K $-4.92K -68.24%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PROKIDNEY CORP.
    • Ticker Symbol: PROK

Search

News categories